T. Rowe Price Investment Management
CNTA

T. Rowe Price Investment Management’s Centessa Pharmaceuticals CNTA Stock Holding History

T. Rowe Price Investment Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$6K Sell
401
-1,752,847
-100% -$26.2M ﹤0.01% 681
2025
Q1 		$25.2M Sell
1,753,248
-1,665,352
-49% -$23.9M 0.02% 491
2024
Q4 		$57.3M Sell
3,418,600
-137,423
-4% -$2.3M 0.04% 388
2024
Q3 		$56.9M Buy
3,556,023
+2,722,030
+326% +$43.5M 0.03% 388
2024
Q2 		$7.53M Buy
+833,993
New +$7.53M ﹤0.01% 556